- Research article
- Open Access
Comparison of uterine and tubal pathology identified by transvaginal sonography, hysterosalpingography, and hysteroscopy in female patients with infertility
© Phillips et al. 2015
- Received: 9 November 2015
- Accepted: 15 December 2015
- Published: 23 December 2015
The causes of female infertility are multifactorial and necessitate comprehensive evaluation including physical examination, hormonal testing, and imaging. Given the associated psychological and financial stress that imaging can cause, infertility patients benefit from a structured and streamlined evaluation. The goal of such a work up is to evaluate the uterus, endometrium, and fallopian tubes for anomalies or abnormalities potentially preventing normal conception. To date, the standard method for assessing these structures typically involves some combination of transvaginal sonography (TVS), hysterosalpingography (HSG), and hysteroscopy (HSC). The goal of this review is to compare the diagnostic accuracy of TVS, HSG, and HSC for diagnosing abnormalities in infertility patients to determine if all studies are necessary for pre-treatment evaluation.
We identified infertility patients prior to initiation of assisted reproductive technology who had baseline TVS, HSG, and HSC within 180 days of each other. From medical record review, we compared frequencies of each finding between modalities. Of the 1274 patients who received a baseline TVS over 2 years, 327 had TVS and HSG within 180 days and 55 patients had TVS, HSG and HSC. Of the 327, TVS detected fibroids more often than HSG (74 vs. 5, p < .0001), and adenomyosis more often than HSG (7 vs. 2, p = .02). HSG detected tubal obstruction more often than TVS (56 vs. 8, p = .002). Four (1.2 %) patients had endometrial polyps on both HSG and TVS.
In the 55 patients with HSG, TVS, and HSC, HSC identified endometrial polyps more often than TVS (10 vs. 1, p = .0001) and HSG (10 vs. 2, p = .0007). TVS detected more fibroids than HSC (17 vs. 5, p < .0001). Tubal obstruction was identified more often by HSG than HSC (19 vs. 5, p < .0001).
TVS is superior for evaluation of myometrial pathology. HSG is superior for evaluation of tubal pathologies. Endometrial pathologies are best identified with HSC.
- Transvaginal sonography
Infertility is defined as the inability for a couple to conceive a pregnancy following 1 year of unprotected vaginal intercourse . It is estimated that 10–15 % of couples seek treatment for infertility [1–3]. It is generally considered appropriate to evaluate a couple for causes of infertility after 1 year of failed attempts at conception. However, given the inverse relationship of female fertility with age, it is often recommended that women over 35 years of age be evaluated after 6 months of failure to conceive, and women older than 40 be evaluated immediately .
A variety of factors may affect normal fertility including patient age, anatomy, ovulatory status, and sperm quality. Potential causes of infertility can be divided into male and female causes and include endocrine, anatomic, genetic, and behavioral conditions . As a result, the evaluation of the infertile couple is multifactorial, necessitating physical examination, hormonal testing, and imaging. Because the infertility population is under a great deal of psychological and emotional stress, these patients benefit from a structured and streamlined evaluation. In particular, evaluation of the female partner attempting to conceive requires assessment of the uterus, endometrium, and fallopian tubes for anomalies or abnormalities potentially preventing normal conception. The best method for assessing these structures usually involves some combination of transvaginal sonography (TVS), hysterosalpingography (HSG), and hysteroscopy (HSC). Less often, pelvic magnetic resonance imaging (MRI) and saline infusion sonohysterography (SIS) are used.
The objective of this paper is to compare the diagnostic accuracy of TVS, HSG, and HSC for diagnosing uterine and tubal abnormalities in women with infertility to determine if all three modalities are necessary in the work up of these patients.
We identified all baseline TVS performed on women in our infertility program from October 12, 2011 to October 12, 2013, prior to their initiation of assisted reproductive techniques (ART). From this group, we narrowed our patient population to those who had an HSG within 180 days of the TVS to maximize the likelihood of concordance between the studies. All TVS and HSG reports were reviewed for tubal, myometrial, or endometrial findings and anatomical variants.
We reviewed patient medical records to identify those patients who also had hysteroscopy (HSC) within 180 days of the baseline TVS, and we recorded the reported findings.
Myometrial abnormalities were categorized as fibroids or adenomyosis; endometrial abnormalities as polyps, cysts, cavity distortion (e.g., synechia, stricture), or nonspecific asymmetry; and tubal abnormalities as obstruction. For each abnormality, the frequency of detection by each modality (TVS, HSG, HSC) was tabulated. For TVS, visualization of a hydrosalpinx was classified as an obstructed fallopian tube. Detection rates of abnormalities were compared among the modalities using the Fisher exact test, with a p-value of <0.05 considered significant.
This study was approved by the Brigham and Women’s Hospital Institutional review board, protocol number 2014P000355.
A total of 1274 patients received a baseline TVS as part of a work up for infertility during the study period. Among these patients, 327 underwent a diagnostic HSG within a 180-day interval of the sonogram and comprise our study population. The time between TVS and HSG was 94 ± 49 days (mean ± SD). Among our 327 study patients, 55 also underwent HSC. The time (mean ± SD) between TVS and HSC was 61 ± 41 days and between HSG and HSC was 61 ± 50 days.
Myometrial, endometrial, and tubal abnormalities detected by transvaginal ultrasound and/or hysterosalpingography (N = 327)
74 (23 %)
p < .0001
7 (2 %)
p < .0001
p < 0.002
56 (17 %)
p < .0001
Myometrial, endometrial, and tubal abnormalities detected by each modality (N = 55)
17 (31 %)
p < .0001 (TVS vs HSC)
6 (11 %)
p = .0001 ( HSC vs TVS)
p = .0007 (HSC vs HSG)
19 (35 %)
<0.0001 (HSG vs HSC)
In this group, TVS detected myometrial abnormalities significantly more often than did HSC, which identified only 4 of the 17 patients with fibroids (p < .0001) and none of the patients with adenomyosis. With respect to endometrial abnormalities, HSC outperformed TSV and HSG, identifying 10 polyps, while TVS only detected 1 (p = .0001) and HSG only 2 (p = .0007). HSG outperformed HSC for tubal obstruction, which only detected 5 of the 19 patients with unilateral or bilateral obstruction (<0.0001)
Diagnostic imaging plays an important role in the assessment of women with infertility. Although no consensus protocol for work up of these patients exists, the majority of infertility patients undergo a baseline TVS and HSG. TVS is used for evaluating ovaries, fallopian tubes, and the adnexa and is a favored imaging modality in the infertility population because it is readily available, relatively low cost, and does not use ionizing radiation. TVS is the test of choice for diagnosing polycystic ovary syndrome , and is helpful for identifying endometriosis and the sequelae of PID. In addition, TVS is invaluable for monitoring ovarian folliculogenesis during treatment with ART [6–8]. In contrast, HSG provides information about tubal patency and uterine cavity abnormalities such as anomalies, polyps, synechiae, and adhesions, any of which could interfere with embryo implantation . However, HSG offers limited evaluation of the cervix and myometrium and does carry the small risks of contrast reaction and of ionizing radiation exposure . Besides TVS and HSG, supplemental evaluation with SIS and hysterosalpingo-contrast sonography (HyCoSy) is sometimes performed. These imaging procedures are becoming more popular because of their ability to combine TVS adnexal evaluation with HSG-like assessment of the uterine cavity, without the risks of contrast reactions and radiation exposure [11–13], but are not yet universally available.
MRI of the pelvis offers multi-planar imaging and does not require the use of ionizing radiation. It is an excellent modality for detecting endometriosis  and is helpful for determine the nature of uterine duplication anomalies, leiomyomas, and adenomysis [14–18]. MRI is also employed for evaluating intracranial causes of infertility, such as pituitary adenomas. However, due to its high cost and limited access, MRI is not typically used in the infertility assessment except for a specific indication requiring such imaging.
At our institution, we begin the infertility assessment with an HSG. If there is evidence of an abnormal uterine cavity from etiologies such as uterine septa, submucosal fibroids, synchiae, or polyps, HSC is then typically performed [19–21]. The standard practice at our institution is to perform HSC in the office setting, reserving operative HSC and laparoscopy for patients who are not able to tolerate office based procedures and for situations for which surgical correction is required, such as septoplasty for the correction of a subseptate uterus. Hysteroscopy is also preformed prior to ART if there is a 6 month or greater delay between the HSG and ART. TVS is obtained when patients begin ART, and continues during folliculogensis.
Our results indicate that TVS is superior to HSG for detection of myometrial pathology, including fibroids and adenomyosis. These results make intuitive sense, as TVS uses high frequency sound waves to evaluate the 3 dimensional volume and echotexture of the uterine tissue, while HSG uses radiographs and contrast dye to outline the endometrial cavity. By assessing the contour of the contrast-filled cavity, information about the surrounding myometrium can be inferred, but not diagnosed, because the tissue itself is not imaged directly. HSG may detect submucosal fibroids, but other myometrial pathology, such as intramural or subserosal fibroids, are likely to be missed. Similarly, TVS is superior to HSC, which visualizes the walls of the uterine cavity but cannot assess for lesions within the myometrium.
A weakness in our study is that we did not assess SIS as a method to evaluate the endometrium. This procedure is included in some protocols during the work up of women with infertility, but is not part of the routine assessment at our institution. SIS has been shown to be superior to TVS for identifying endometrial abnormalities including polyps and cavity distortion [11, 13, 22–27]. Some reports have also shown SIS to be comparable to the gold standard of HSC for evaulation of intrauterine abnormalities including polyps, submucosal fibroids, adhesions and uterine anomalies, with a sensitivity and specificity for detection of 88 and 94 %, respectively [28, 29]. In addition, none of our patients were evaluated by HyCoSy, a procedure that uses aerated saline or contrast to assess tubal patency with TVS. HyCoSy has been shown to be comparable to HSG with regards to assessing tubal patency, with sensitivity ranges from 75–96 % and specificity from 67–100 % [12, 13, 30, 31]. SIS and HyCoSy can be done in a single visit and together provide information about the uterine cavity and the patency of the fallopian tubes, similar to HSG, but with added information about the myometrium from the TVS component, all without exposure to ionizing radiation or iodinated contrast. Despite these advantages, HyCoSy does not provide anatomical information about the fallopian tubes, which limits its utility.
Given the lack of a single all encompassing imaging tool for accurately diagnosing endometrial, tubal, and myometrial causes of infertility, it could be helpful to outline one step-wise approach for use of the TVS, HSG, and HSC. Although there is tremendous variability between practices, at our institution most infertility patients undergo both a TVS and HSG prior to initiating ART. Others have found that SIS and HyCoSy provide comparable information as TVS and HSG combined. If findings of these tests suggest an abnormality within the uterine cavity, which could prevent implantation of a viable gestational sac, the patient will be referred for a HSC for direct inspection and possible treatment. However, the management of abnormal tubal pathology on HSG will vary depending on plan for reproductive therapy. If the patient is an In-vitro Fertilization (IVF) candidate, tubal obstruction is not of much consequence, as the embryo is directly implanted into the uterus. However, if the patient is not a candidate for IVF, tubal obstruction can be further managed with surgical interventions such as tuboplasty or salpingostomy.
Our study compared the results from TVS, HSG, and HSC in a cohort of female infertility patients. TVS was superior for detecting myometrial pathology, HSG was superior for evaluating tubal patency, and HSC detected more endometrial polyps than HSG and TVS. No single modality provided accurate identification of all different pathologies. Complete work up of women with infertility may include all modalities, given the unique information obtained from each. However, with knowledge of the unique specificity of each imaging test to detect specific pathologies, a combination of HSG, HSC and TVS could be selected based on the clinical presentation of patients.
No other persons, besides those mentioned in the authorship, significantly contributed towards this study. There were no sources of funding for this research paper, all authors dedicated their academic time towards the preparation and design of this study.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- McLaren JF. Infertility evaluation. Obstet Gynecol Clin North Am. 2012;39:453–63.PubMedView ArticleGoogle Scholar
- Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of U.S. women: data from 2002 National Survey of Family Growth. Vital Health Stat. 2012;23:1–160.Google Scholar
- Chandran A, Copen CE, Stephen EH. Infertility service use in the United States: Data from the National survey of Family Growth, 1982-2010. http://www.cdc.gov/nchs/data/nhsr/nhsr073.pdf
- Sadow CA, Sahni VA. Imaging female infertility. Abdom Imaging. 2014;39:92–107.PubMedView ArticleGoogle Scholar
- Wall DJ, Javitt MC, Glanc P, Bhosale PR, Harisinghani MG, Harris RD, et al. ACR appropriateness criteria infertility. Ultrasound Q. 2015;31:37–44.PubMedView ArticleGoogle Scholar
- Langer JE, Oliver ER, Lev-Toaff AS, Coleman BG. Imaging of the female pelvis throughout the life cycle. Radiographics. 2012;32:636–9.View ArticleGoogle Scholar
- Hendriks DJ, Mol BW, Bancsi LF, Te Veide Er, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005;83:291–301.PubMedView ArticleGoogle Scholar
- De Crespigny LC, O’Herlihy C, Robinson HP. Ultrasonic evaluation of the mechanism of human ovulation. Am J Obstet Gynecol. 1981;139:636–9.PubMedGoogle Scholar
- Simpson WL, Beitia LG, Mester J. Hysterosalpingography: a reemerging study. Radiographics. 2006;26:419–31.PubMedView ArticleGoogle Scholar
- Baramki TA. Hysterosalpingography. Fertil Steril. 2005;83:1595–606.PubMedView ArticleGoogle Scholar
- O’Neill MJ. Sonohysterography. Radio Clin North Am. 2003;41:781–97.View ArticleGoogle Scholar
- Schlief R, Deichert U. Hysterosalpingo-contrast sonography of the uterus and fallopian tubes: results of a clinical trial of a new contrast medium in 120 patients. Radiology. 1991;178:213–5.PubMedView ArticleGoogle Scholar
- Saunders RD, Shwayder JM, Nakajima ST. Current methods of tubal patency assessment. Fertil Steril. 2001;95:2171–9.View ArticleGoogle Scholar
- Behr SC, Courtier JL, Qayyam A. Imaging of Mullerian duct anomalies. Radiographics. 2012;32:E233–50.PubMedView ArticleGoogle Scholar
- Marcal L, Nothaft MA, Coelho F, Volpato R, Iyer R. Mullerian duct anomalies: MR imaging. Abdom Imaging. 2011;36:756–64.PubMedView ArticleGoogle Scholar
- Tamai K, Togashi K, Ito T, Morisawa N, Fujiwara T, Koyama T. MR imaging findings of adenomyosis: correlation with histopathologic features and diagnostic pitfalls. Radiographics. 2005;25:21–40.PubMedView ArticleGoogle Scholar
- Deshmukh SP, Gonsalves CF, Guglielmo FF, Mitchell DG. Role of MR imaging of uterine leiomyomas before and after embolization. Radiographics. 2012;32:E251–81.PubMedView ArticleGoogle Scholar
- Steinkeler JA, Woodfield CA, Lazarus E, Hillstrom MM. Female infertility: a systematic approach to radiologic imaging and diagnosis. Radiographics. 2009;29:1353–70.PubMedView ArticleGoogle Scholar
- American Collecte of Obstetricians and Gynecologists. ACOG technology assessment in obstetrics and gynecology: hysteroscopy. Obstet Gynecol. 2005; 106:439–42.View ArticleGoogle Scholar
- Bozgad G, Aksan G, Esinler I, Yarali H. What is the role of office hysteroscopy in women with failed IVF cycles. Reprod Biomed Online. 2008;17(23):410–5.Google Scholar
- Molinas CR, Campo R. Office hysteroscopy and adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20:557–67.PubMedView ArticleGoogle Scholar
- Randolph JF, Ying YK, Maier DB, Schmidt CL, Riddick DH. Comparison of real-time ultrasonography, hysterosalpingography, and laparoscopy/hysteroscopy in the evaluation of uterine abnormalities and tubal patency. Fertil Steril. 1986;46:828–32.PubMedGoogle Scholar
- Acholonu UC, Silberzweig J, Stein DE, Keltz M. Hysterosalpingography versus sonohysterography for intrauterine abnormalities. J Soc Lap Surg. 2011;15:471–4.Google Scholar
- Bonilla-Musoles F, Simon C, Serra V, Sampaio M, Pellicer A. An assessment of hysterosalpingosonography (HSSG) as a diagnostic tool for uterine cavity defects and tubal patency. J Clin Ultrasound. 1992;20:175–81.PubMedView ArticleGoogle Scholar
- Kim AH, McKay H, Keltz MD, Nelson HP, Adamson GD. Sonohysterographic screening before in vitro fertilization. Fert Steril. 1998;69:841–4.View ArticleGoogle Scholar
- Ragni G, Diaferia D, Vegetti W, Colombo M, Arnoldi M, Crosignani PG. Effectiveness of sonohysterography in infertile patient work-up: a comparison with transvaginal ultrasonography and hysteroscopy. Gynecol Obstet Invest. 2005;59:184–8.PubMedView ArticleGoogle Scholar
- Yang T, Pandya A, Marcal L, Bude RO, Platt JF, Bedi DG, et al. Sonohysterography: principles, technique and role in diagnosis of endometrial pathology. World J Radiol. 2013;5:81–7.PubMedPubMed CentralView ArticleGoogle Scholar
- Seshadri S, El-Toukhy T, Douiri A, Jayaprakasan K, Khalaf Y. Diagnostic accuracy of saline infusion sonography in the evaluation of uterine cavity abnormalities prior to assisted reproductive techniques: a systematic review and meta-analyses. Hum Reprod Update. 2015;21(2):262–74.PubMedView ArticleGoogle Scholar
- La Sala GB, Blasi I, Gallinelli A, Debbi C, Lopopolo G, Vinci V, et al. Diagnostic accuracy of sonohysterography and transvaginal sonography as compared to hysteroscopy and endometrial biopsy: a prospective study. Minerva Ginecol. 2011;63(5):421–7.PubMedGoogle Scholar
- Exacoustos C, Zupi E, Carusotti C, Lanzi G, Marconi D, Arduini D. Hysterosalpingo-contrast sonography compared with hysterosalpingography and laparoscopic dye pertubation to evaluate tubal patency. J Am Assoc Gynecol Laparosc. 2003;10:376–72.Google Scholar
- Luciano DE, Exacoustos C, Luciano AA. Contrast ultrasonography for tubal patency. J Min Invasive Gynecol. 2014;21:994–8.View ArticleGoogle Scholar